Medications That Can Cause Gout

Medically Reviewed By William C. Lloyd III, MD, FACS
— Written By Healthgrades Editorial Staff
Updated on August 11, 2022

Gout, a complex form of arthritis, is characterized by sudden, severe attacks of pain, swelling, redness, and tenderness in the joints, often the big toe. This inflammatory condition arises from an accumulation of uric acid in the bloodstream, leading to the formation of uric acid crystals within the joints. While dietary factors, particularly foods rich in purines like dried beans and organ meats, are well-known contributors to elevated uric acid levels, it is crucial to recognize that certain medications can also significantly influence this delicate balance within the body. Understanding these pharmaceutical culprits is vital for effective gout management and prevention.

The body naturally produces uric acid as it breaks down purines, substances found in many foods. Normally, the kidneys efficiently filter uric acid from the blood, excreting it through urine. However, when uric acid production increases, or the kidneys' ability to remove it decreases, levels can rise, triggering a gout attack. While dietary modifications are often discussed in relation to gout, the role of prescription and over-the-counter medications in this process is frequently overlooked. Patients experiencing gout symptoms while on specific treatments should always discuss potential connections with their healthcare provider, as medication adjustments may be necessary.

This article explores several medication classes and specific drugs that have been identified as potential contributors to increased uric acid levels and, consequently, a higher risk of gout flares. It is important to remember that these medications are often prescribed for serious health conditions, and their benefits typically outweigh the potential risks for many individuals. Therefore, patients should never discontinue or alter their prescribed medications without explicit guidance from their physician. A well-informed discussion with a healthcare professional is paramount for navigating treatment options safely and effectively.

Getty

You already know that eating foods rich in purines like dried beans and liver can lead to a buildup of uric acid in the blood. But those aren’t the only culprits that contribute to gout. Certain medications used to treat other conditions may increase uric acid levels, too. If you take one of the medications listed below and experience gout, it’s worth asking your doctor if there could be a connection.

Diuretics (Diuril, Saluron, Thalitone)

Diuretics, commonly known as "water pills," are frequently prescribed to manage a range of conditions, including high blood pressure and heart failure. Their primary mechanism of action involves prompting the kidneys to excrete more sodium and water, which helps reduce fluid retention and lower blood pressure. However, this process can inadvertently affect the body's uric acid metabolism. Among medications known to elevate uric acid levels, diuretics are considered particularly problematic, significantly increasing the risk of gout attacks.

The connection between diuretics and gout lies in their impact on kidney function. While these medications effectively help the body eliminate excess fluid, they can concurrently diminish the kidneys' efficiency in filtering and removing uric acid from the bloodstream. This impaired excretion leads to an accumulation of uric acid, causing a rise in blood levels. When uric acid concentrations become sufficiently high, the formation of sharp, needle-like crystals in the joints can occur, precipitating the excruciating pain and inflammation characteristic of a gout attack. Studies indicate that diuretics can boost the risk of gout attacks by approximately 20%.

Given their widespread use in managing cardiovascular conditions, the potential for diuretics to induce or exacerbate gout requires careful consideration. Patients taking these medications who begin to experience gout symptoms should promptly inform their doctor. While the benefits of diuretics for conditions like hypertension or heart failure are often substantial, alternative treatments or concurrent gout-preventative strategies might be explored to mitigate the risk of uric acid buildup and subsequent gout flares, ensuring comprehensive patient care.

Aspirin

Aspirin is a widely available pain reliever and anti-inflammatory drug, and its low-dose formulation is often prescribed for its anticoagulant properties to prevent heart attacks and strokes. Given its general pain-relieving effects, one might instinctively consider it a suitable option for alleviating gout symptoms. However, using aspirin for gout can have the paradoxical effect of worsening the condition, rather than improving it. This counterintuitive outcome stems from aspirin's influence on the kidneys' ability to process uric acid, particularly at lower doses.

At typical analgesic or antiplatelet doses (e.g., 81 mg to 325 mg), aspirin interferes with the kidneys' capacity to excrete uric acid effectively. It can inhibit the tubular secretion of uric acid in the kidneys, leading to its retention in the body and a subsequent increase in blood uric acid levels. This rise in uric acid concentrations can trigger or exacerbate gout attacks, making aspirin an unsuitable choice for managing gout-related pain. Paradoxically, very high doses of aspirin, far exceeding those used for pain relief or cardiovascular prevention, can actually promote uric acid excretion, but such doses carry significant risks and are not clinically recommended for gout management.

Consequently, healthcare providers advise against using aspirin for the treatment of gout pain or inflammation. Instead, they will typically recommend other classes of pain relievers, such as nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen (at appropriate, non-aspirin doses), or colchicine, which are more effective and safer for managing acute gout flares without contributing to uric acid buildup. Patients already taking low-dose aspirin for cardiovascular health who develop gout should consult their doctor to discuss their overall treatment plan, ensuring that all medications are optimized for their health needs.

Niacin

Niacin, also known as vitamin B3, plays a vital role in various bodily functions, including metabolism and nerve function. In its prescription form, niacin is a well-established medication used to manage elevated cholesterol levels, particularly lowering low-density lipoprotein (LDL) cholesterol and triglycerides while increasing high-density lipoprotein (HDL) cholesterol. Beyond prescription strength, lower doses of niacin are readily available as dietary supplements, often touted for their general health benefits. However, when consumed in very large quantities, specifically 3 grams or more per day, niacin can contribute to several serious health problems, including the development or exacerbation of gout.

The mechanism by which high-dose niacin can contribute to gout involves its impact on uric acid metabolism. While lower doses are generally well-tolerated, excessive intake can impair the kidneys' ability to excrete uric acid effectively. This reduced renal clearance leads to an accumulation of uric acid in the bloodstream, increasing the risk of uric acid crystal formation and subsequent gout attacks. This effect is particularly pronounced with extended-release forms of niacin and in individuals already predisposed to elevated uric acid levels.

Therefore, individuals taking high-dose prescription niacin for cholesterol management, or those considering high-dose niacin supplements, should be aware of this potential side effect. Regular monitoring of uric acid levels may be advisable for these patients. For those who experience gout symptoms while on niacin, a discussion with their prescribing physician is essential to evaluate whether the benefits of niacin therapy outweigh the risks, or if alternative cholesterol-lowering treatments or gout-specific interventions are more appropriate to maintain overall health and prevent recurrent gout flares.

Levodopa (Sinemet and Stalevo)

Levodopa is a cornerstone medication in the treatment of Parkinson's disease, a progressive neurological disorder that affects movement. It works by converting into dopamine in the brain, helping to replenish the diminished dopamine levels that are characteristic of Parkinson's disease, thereby improving motor symptoms such as tremors, rigidity, and bradykinesia (slow movement). While highly effective in managing the debilitating symptoms of this condition, levodopa is also recognized for its ability to increase uric acid levels in the body, presenting a potential concern for patients with or at risk of gout.

The increase in uric acid associated with levodopa use is primarily due to its metabolic pathway. Levodopa and its metabolites, when broken down in the body, can contribute to the endogenous production of uric acid. This elevation in uric acid can be significant enough to trigger gout attacks in susceptible individuals. For patients managing a chronic condition like Parkinson's disease, the emergence of gout can add another layer of complexity to their health management, impacting their quality of life and potentially complicating their existing treatment regimen.

Given the critical role of levodopa in Parkinson's therapy, discontinuing it due to gout risk is generally not a viable option. Instead, management strategies often involve close monitoring of uric acid levels in Parkinson's patients receiving levodopa. If gout develops, a physician may consider prescribing medications to lower uric acid levels or manage acute gout flares, such as allopurinol or colchicine, while continuing levodopa therapy. This integrated approach ensures that patients can continue to benefit from their Parkinson's treatment while mitigating the risk and impact of gout.

Cyclosporine (Gengraf, Neoral, Sandimmune)

Cyclosporine is a powerful immunosuppressant medication primarily used in organ transplant recipients to prevent the body's immune system from rejecting the transplanted organ. By suppressing immune responses, it helps the new organ integrate successfully into the patient's body. Beyond transplantation, cyclosporine is also utilized in treating certain autoimmune diseases, such as severe psoriasis and rheumatoid arthritis, where it helps modulate an overactive immune system. However, a notable side effect of this essential medication is its propensity to increase uric acid levels, thereby heightening the risk of gout.

The mechanism by which cyclosporine elevates uric acid levels is multifaceted. It can impair the kidneys' ability to excrete uric acid, leading to its accumulation in the blood. Additionally, some research suggests it may also influence the production of uric acid. For transplant patients, who are often on multiple medications and may have other risk factors, the development of gout can complicate their recovery and long-term health. The increase in uric acid can lead to significant pain and inflammation, further stressing an already fragile system.

Managing gout in patients on cyclosporine requires a careful balance between preserving the transplanted organ's function and addressing the musculoskeletal pain. Physicians will often monitor uric acid levels closely in patients receiving cyclosporine. If gout develops, specific anti-gout medications may be introduced to lower uric acid levels or to manage acute attacks. It is crucial for patients never to adjust their cyclosporine dosage independently, as this could lead to organ rejection. All treatment decisions, including the management of gout, must be made in close consultation with the transplant team and other specialists to ensure optimal health outcomes.

The intricate relationship between certain medications and uric acid levels underscores the importance of a holistic approach to patient care. While diet and lifestyle choices are commonly recognized factors in gout development, the pharmacological landscape also plays a significant role. Medications prescribed for conditions ranging from cardiovascular health to neurological disorders and organ transplantation can inadvertently influence the body’s ability to regulate uric acid, thereby increasing the risk of gout attacks. Understanding these links empowers both patients and healthcare providers to anticipate and address potential challenges.

For individuals currently taking any of the medications discussed—diuretics, aspirin, niacin, levodopa, or cyclosporine—and experiencing symptoms consistent with gout, a proactive discussion with your physician is absolutely essential. It is vital to never discontinue or modify your prescribed medication regimen without professional medical advice, as these drugs often manage critical health conditions. Your doctor can assess your individual risk factors, evaluate the necessity of your current medications, and explore strategies to mitigate gout risk, such as adjusting dosages, prescribing alternative treatments, or initiating specific uric acid-lowering therapies.

Ultimately, effective management of gout, particularly when medication-induced, hinges on collaborative decision-making between patient and physician. This partnership ensures that all aspects of your health are considered, leading to a tailored treatment plan that minimizes the risk of gout flares while effectively managing your primary health conditions. By maintaining open communication and adhering to professional medical guidance, individuals can navigate the complexities of their medication regimens and achieve better overall health outcomes.

View Sources

1. Arthritis Foundation (http://www.arthritis.org/disease-center.php?disease_id=42&df=definition);
2. US Food and Drug Administration (http://www.fda.gov/ForConsumers/ByAudience/ForWomen/ucm118594.htm);
3. National Institute of Arthritis and Musculoskeletal and SKin Diseases (http://www.niams.nih.gov/Health_Info/Gout/default.asp#foods);
4. National Library of Medicine (http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601068.html);
5. National Library of Medicine (http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601207.html);
6. National Library of Medicine (http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682878.html);
7. National Library of Medicine (http://www.nlm.nih.gov/medlineplus/druginfo/natural/924.html);
8. National Library of Medicine (http://www.nlm.nih.gov/medlineplus/ency/article/003476.htm);
9. National Library of Medicine (http://www.nlm.nih.gov/medlineplus/ency/patientinstructions/000112.htm);
10. National Library of Medicine (http://www.nlm.nih.gov/medlineplus/tutorials/gout/id219103.pdf);
11. American College of Rheumatology (http://www.rheumatology.org/practice/clinical/patients/diseases_and_conditions/gout.asp);

THIS TOOL DOES NOT PROVIDE MEDICAL ADVICE. It is intended for informational purposes only. It is not a substitute for professional medical advice, diagnosis or treatment. Never ignore professional medical advice in seeking treatment because of something you have read on the site. If you think you may have a medical emergency, immediately call your doctor or dial 911.

Medically Reviewed By William C. Lloyd III, MD, FACS
— Written By Healthgrades Editorial Staff
Updated on August 11, 2022

Original article: https://resources.healthgrades.com/right-care/gout/certain-medications-can-cause-gout?hid=nxtup/#niacin